
Laicuinuo LCN
Ordered peptides from Laicuinuo LCN? Mail in a sample (US only) and let us test it.
Test my supplyLaicuinuo LCN's purity-focus record is strongest on GHK-Cu and Tirzepatide, with generally solid identity/purity evidence but notable Tirzepatide fill volatility. Retatrutide remains mixed despite later passes, with identity failures, extreme overfills and a recent purity miss; BPC-157 and Tesamorelin are sparse and uncertain.
Corporate records point to a UK Xingruida wrapper in strike-off posture, while HK/CN registry searches do not confirm the storefront’s branding. Mirrored domains, shared infrastructure, and direct-payment rails create the authentication story behind the lab numbers.
Unlock original COAs
View and download original lab PDFs for Finnrick tests, including Laicuinuo LCN rows.
Cancel anytime
Ordered peptides from Laicuinuo LCN? Mail in a sample (US only) and let us test it.
Test my supply| Date | Result | Test | Lab | Purity | Dosage | Label | COA |
|---|---|---|---|---|---|---|---|
10 Nov 2026 | Pass | Retatrutide Laicuinuo LCN | lab name | View COA | |||
29 Oct 2026 | Pass | Retatrutide Laicuinuo LCN | lab name | View COA | |||
5 Oct 2026 | Fail | Retatrutide Laicuinuo LCN | lab name | View COA | |||
30 Sep 2026 | Pass | Retatrutide Laicuinuo LCN | lab name | View COA | |||
30 Sep 2026 | Pass | Retatrutide Laicuinuo LCN | lab name | View COA | |||
24 Sep 2026 | Fail | BPC-157 Laicuinuo LCN | lab name | View COA | |||
24 Sep 2026 | Fail | GHK-Cu Laicuinuo LCN | lab name | View COA | |||
24 Sep 2026 | Fail | Tirzepatide Laicuinuo LCN | lab name | View COA | |||
16 Sep 2026 | Fail | Tirzepatide Laicuinuo LCN | lab name | View COA | |||
15 Sep 2026 | Pass | GHK-Cu Laicuinuo LCN | lab name | View COA | |||
About Laicuinuo LCN test results from Finnrick
Laicuinuo LCN is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 6 peptides and 48 tests, including ratings, observed price signals, recent test dates, and correction history where available.
Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.
The most visible Laicuinuo LCN peptides in this dataset are BPC-157 (3 tests), CJC-1295 (3 tests) and GHK-Cu (4 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.
Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 48 recent tests.
Ordered peptides from Laicuinuo LCN? Mail in a sample (US only) and let us test it.
Test my supply